SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
Clinical trial NCT03066947 · COMPLETED
Trial details
- NCT number
- NCT03066947
- Sponsor
- BriaCell Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-05
- Primary completion
- 2018-11-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.